Notably, male BRCA2 PVs carriers are significantly more likely to develop cancer, particularly BC, and are at increased risk of developing second breast and non-breast tumors, compared to male BRCA1 PVs carriers [72]. This evidence concerns the gene BRCA1 and breast cancer.